Inovio Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (INO)

Q: What does CUSIP 45773H409 represent in this 13F holders report?

CUSIP 45773H409 is the security identifier for INO - Inovio Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held INO - Inovio Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in Q4 2025?

99 institutional investors reported INO - Inovio Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 45773H409

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 72,491,935
Total 13F shares: 33,075,486
Share change: +12,371,821
Total reported value: $57,545,239
Put/Call ratio: 13%
Price per share: $1.74
Number of holders: 99
Value change: +$21,224,322
Number of buys: 43
Number of sells: 39

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - Inovio Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026
Previous quarter: Q3 2025

Recent filing periods for CUSIP 45773H409:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of INO - Inovio Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
JANUS HENDERSON GROUP PLC	13D/G 13F	Company	10%	6,666,295	$12,999,275	+$6,630,068	28 Nov 2025	13D/G 13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	4.7%	3,428,571	$8,022,856	—	30 Sep 2025	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13D/G	—	9.2%	3,633,333	$6,794,333	$0	31 Dec 2024	13D/G
Alyeska Investment Group, L.P.	13D/G	—	6%	4,000,000	$6,400,000	$0	31 Dec 2025	13D/G
VANGUARD GROUP INC	13F 13D/G	Company · The Vanguard Group	5% from 13D/G	2,712,872	$6,348,120	—	30 Sep 2025	13F 13D/G
Boxer Capital Management, LLC	13F	Company	3.2%	2,300,000	$5,382,000	—	30 Sep 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.7%	1,972,518	$4,615,692	—	30 Sep 2025	13F
Deep Track Capital, LP	13D/G	—	2.4%	1,314,796	$3,076,623	$0	30 Sep 2025	13D/G
Stonepine Capital Management, LLC	13D/G	—	3.8%	1,434,997	$2,683,444	-$900,721	31 Mar 2025	13D/G
Jong Joseph Kim	3/4/5	Chief Executive Officer, Director	— mixed-class rows	3,113,086 mixed-class rows	$2,451,149	—	11 Mar 2022	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.1%	816,339	$1,910,233	—	30 Sep 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	1.1%	806,742	$1,887,776	—	30 Sep 2025	13F
MORGAN STANLEY	13F	Company	1.1%	786,774	$1,841,053	—	30 Sep 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.88%	636,061	$1,488,383	—	30 Sep 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.75%	546,747	$1,279,649	—	30 Sep 2025	13F
BlackRock, Inc.	13F 13D/G	Company	1.5% from 13D/G	499,403	$1,168,603	—	30 Sep 2025	13F 13D/G
GSA CAPITAL PARTNERS LLP	13F	Company	0.61%	443,104	$1,037,000	—	30 Sep 2025	13F
UBS Group AG	13F	Company	0.4%	293,062	$685,765	—	30 Sep 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.4%	290,800	$680,472	—	30 Sep 2025	13F
NORTHERN TRUST CORP	13F	Company	0.33%	238,471	$558,022	—	30 Sep 2025	13F
XTX Topco Ltd	13F	Company	0.29%	210,567	$492,727	—	30 Sep 2025	13F
STATE STREET CORP	13F	Company	0.26%	186,210	$435,731	—	30 Sep 2025	13F
ROYAL BANK OF CANADA	13F	Company	0.23%	165,408	$387,000	—	30 Sep 2025	13F
GMT CAPITAL CORP	13F	Company	0.17%	126,119	$295,118	—	30 Sep 2025	13F
Headlands Technologies LLC	13F	Company	0.15%	110,068	$257,559	—	30 Sep 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.15%	108,701	$254,360	—	30 Sep 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.09%	65,206	$152,583	—	30 Sep 2025	13F
HRT FINANCIAL LP	13F	Company	0.09%	65,065	$152,000	—	30 Sep 2025	13F
Concurrent Investment Advisors, LLC	13F	Company	0.08%	56,011	$131,066	—	30 Sep 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	53,711	$125,683	—	30 Sep 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	51,182	$119,766	—	30 Sep 2025	13F
Green Alpha Advisors, LLC	13F	Company	0.07%	48,088	$112,526	—	30 Sep 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.05%	37,991	$89,057	—	30 Sep 2025	13F
Quadrature Capital Ltd	13F	Company	0.05%	37,115	$86,849	—	30 Sep 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.05%	33,496	$78,381	—	30 Sep 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.04%	32,106	$75,128	—	30 Sep 2025	13F
LPL Financial LLC	13F	Company	0.04%	25,995	$60,828	—	30 Sep 2025	13F
Simon X. Benito	3/4/5	Director	— mixed-class rows	17,275 mixed-class rows	$51,120	—	21 May 2025	3/4/5
Greenwich Wealth Management LLC	13F	Company	0.03%	20,399	$48,000	—	30 Sep 2025	13F
Wendy L. Yarno	3/4/5	Director	— mixed-class rows	15,596 mixed-class rows	$47,980	—	21 May 2025	3/4/5
Ann C. Miller	3/4/5	Director	— mixed-class rows	14,961 mixed-class rows	$46,792	—	21 May 2025	3/4/5
Jay Shepard	3/4/5	Director	— mixed-class rows	14,293 mixed-class rows	$45,543	—	21 May 2025	3/4/5
ZACKS INVESTMENT MANAGEMENT	13F	Company	0.03%	19,455	$45,525	—	30 Sep 2025	13F
Roger D. Dansey	3/4/5	Director	— mixed-class rows	14,000 mixed-class rows	$44,995	—	21 May 2025	3/4/5
Lota S. Zoth	3/4/5	Director	— mixed-class rows	13,810 mixed-class rows	$44,640	—	21 May 2025	3/4/5
Prime Capital Investment Advisors, LLC	13F	Company	0.03%	18,453	$43,180	—	30 Sep 2025	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.02%	17,673	$41,355	—	30 Sep 2025	13F
BANK OF MONTREAL /CAN/	13F	Company	0.02%	17,382	$40,674	—	30 Sep 2025	13F
RAYMOND JAMES FINANCIAL INC	13F	Company	0.02%	16,680	$39,031	—	30 Sep 2025	13F
Focus Partners Wealth	13F	Company	0.02%	14,289	$33,437	—	30 Sep 2025	13F

Institutional Holders of Inovio Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (INO) as of Q4 2025

As of 31 Dec 2025, Inovio Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (INO) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,075,486 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Boxer Capital Management, LLC, D. E. Shaw & Co., Inc., ADAR1 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock, Inc.. This page lists 99 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.